Handelsbanken Fonder’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
MGP
Handelsbanken Fonder's DGX Position: Q2 2026 in Review
Handelsbanken Fonder reduced its Quest Diagnostics (DGX) stake by 2.5% in Q2 2026, selling an estimated $174K and leaving 34,476 shares worth $7.31M. The position accounts for 0.02% of the portfolio, ranked #423.
Handelsbanken Fonder first reported a position in DGX in Q4 2015 and has held it in 26 quarters since. The position peaked at $14.5M in Q2 2023. 736 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Handelsbanken Fonder held 34,476 shares of Quest Diagnostics worth $7.31M as of Q2 2026.
- Handelsbanken Fonder sold 885 Quest Diagnostics shares in Q2 2026, an estimated $174K.
- Quest Diagnostics made up 0.02% of Handelsbanken Fonder's portfolio in Q2 2026, its #423 holding.
- Handelsbanken Fonder first reported a position in Quest Diagnostics in Q4 2015 and has held it in 26 quarters since.
- Handelsbanken Fonder's Quest Diagnostics position peaked at $14.5M in Q2 2023.
- 736 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.